Search research articles
Contact Us
Filters
Showing results (171-180 of 281) with videos related to
Page
of 29
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 26, 2023
Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD
L Parker Gregg, David J Ramsey, Julia M Akeroyd, et al.
Kidney International Reports
|
October 27, 2025
Kidney Function Trajectories With Mechanical Circulatory Support
Carl P Walther, Harveen K Lamba, Ajith P Nair, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 18, 2013
Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population
Jonathan J Taliercio, Jesse D Schold, James F Simon, et al.
Journal of Diabetes and Its Complications
|
March 1, 2023
Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice
Nihar R Desai, Sankar D Navaneethan, Susanne B Nicholas, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 25, 2023
Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD
L Parker Gregg, Melandrea L Worsley, David J Ramsey, et al.
American Journal of Nephrology
|
November 26, 2018
Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014)
Ahmed A Awan, Jingbo Niu, Jenny S Pan, et al.
The Cochrane Database of Systematic Reviews
|
April 17, 2009
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Sankar D Navaneethan, Francesca Pansini, Vlado Perkovic, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 16, 2013
Metabolic syndrome, ESRD, and death in CKD
Sankar D Navaneethan, Jesse D Schold, John P Kirwan, et al.
Journal of the American Society of Nephrology : JASN
|
June 11, 2016
Pragmatic Clinical Trials in CKD: Opportunities and Challenges
Ian H de Boer, Csaba P Kovesdy, Sankar D Navaneethan, et al.
The American Journal of Cardiology
|
March 20, 2022
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs)
Mahmoud Al Rifai, Elizabeth M Vaughan, Layla A Abushamat, et al.
Page
of 29
Search research articles
Search
Showing results (171-180 of 281) with videos related to
Sort By:
Page
of 29
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 26, 2023
Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD
L Parker Gregg, David J Ramsey, Julia M Akeroyd, et al.
Kidney International Reports
|
October 27, 2025
Kidney Function Trajectories With Mechanical Circulatory Support
Carl P Walther, Harveen K Lamba, Ajith P Nair, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 18, 2013
Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population
Jonathan J Taliercio, Jesse D Schold, James F Simon, et al.
Journal of Diabetes and Its Complications
|
March 1, 2023
Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice
Nihar R Desai, Sankar D Navaneethan, Susanne B Nicholas, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 25, 2023
Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD
L Parker Gregg, Melandrea L Worsley, David J Ramsey, et al.
American Journal of Nephrology
|
November 26, 2018
Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014)
Ahmed A Awan, Jingbo Niu, Jenny S Pan, et al.
The Cochrane Database of Systematic Reviews
|
April 17, 2009
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Sankar D Navaneethan, Francesca Pansini, Vlado Perkovic, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 16, 2013
Metabolic syndrome, ESRD, and death in CKD
Sankar D Navaneethan, Jesse D Schold, John P Kirwan, et al.
Journal of the American Society of Nephrology : JASN
|
June 11, 2016
Pragmatic Clinical Trials in CKD: Opportunities and Challenges
Ian H de Boer, Csaba P Kovesdy, Sankar D Navaneethan, et al.
The American Journal of Cardiology
|
March 20, 2022
Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs)
Mahmoud Al Rifai, Elizabeth M Vaughan, Layla A Abushamat, et al.
Page
of 29